uniQure N.V.
NASDAQ:QUREBiotechnology
-$1.13 today
- Market cap
- $1.42B
- Beta
- 1.00
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$3.33
Volume 1.13M
Average 1.75M
QURE Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
uniQure N.V.NASDAQ: QURE
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents falls 35.6% from a year ago
Cash & equivalents stood at $139.99M at the end of Q1 FY2026, down 35.6% from a year earlier and up 74.5% from the prior quarter. Over 3 fiscal years it compounded at -29.4% a year.
Context
- Cash & equivalents amounted to 18.0% of total assets at the end of Q1 FY2026, down 17.9 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -35.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 80.24M USD
- Year-over-year change
- -49.5%
- 4-year CAGR
- -38.4%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 80.24M | -49.5% |
| FY2024 | 2024-12-31 | 158.93M | -34.2% |
| FY2023 | 2023-12-31 | 241.36M | +5.9% |
| FY2022 | 2022-12-31 | 228.01M | -59.0% |
| FY2021 | 2021-12-31 | 556.26M | — |
Cash & Equivalents vs competitors
How QURE compares with its peers on the latest reported figures
- QURE's Mar 2026 cash & equivalents of $139.99M is the 2nd highest of the 8 companies compared; the peer median is $71.54M.
- Its year-over-year change of -35.6% is the 5th highest of 8, against a peer median of -0.4%.
- Cash & equivalents amounts to 18.0% of total assets for QURE, versus a peer median of 17.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $175M | +37.7% | +48.3% | 13.5% | |
| Mar 2026 | $139.99M | -35.6% | -29.4% | 18.0% | |
| Mar 2026 | $124.16M | +75.4% | +8.2% | 47.2% | |
| Mar 2026 | $72.49M | -45.7% | +4.8% | 14.1% | |
| Mar 2026 | $71.54M | +7.5% | -17.1% | 29.2% | |
| Mar 2026 | $49.61M | -0.4% | -18.0% | 17.4% | |
| Mar 2026 | $43.31M | -42.1% | -12.9% | 19.7% | |
| Mar 2026 | $15.23M | -88.3% | -29.2% | 4.5% | |
| Peer median (excluding QURE) | $71.54M | -0.4% | -12.9% | 17.4% | |
Competitors are the stored peer set for QURE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 556.26M | 228.01M | 241.36M | 158.93M | 80.24M |
| Short-term Investments | 0 | 124.83M | 376.53M | 208.59M | 542.3M |
| Net Receivables | 58.77M | 102.38M | 4.19M | 5.88M | 5.86M |
| Inventory | 0 | 6.92M | 12.02M | 0 | 0 |
| Other Current Assets | 2.68M | 2.81M | 2.66M | 7.61M | 7.08M |
| Total Current Assets | 628.24M | 476.77M | 651.85M | 390.29M | 655.99M |
| Property, Plant & Equipment (Net) | 69.08M | 83.26M | 75.34M | 34.07M | 26.33M |
| Goodwill | 27.63M | 25.58M | 26.38M | 22.41M | 25.36M |
| Intangible Assets | 62.69M | 58.78M | 60.48M | 71.04M | 72.79M |
| Long-term Investments | 0 | 39.98M | 2.18M | 27.46M | 30.24M |
| Tax Assets | 15.65M | 14.53M | 12.28M | 9.86M | 8.65M |
| Other Non-current Assets | 5.9M | 6.06M | 3.18M | 1.4M | 5.56M |
| Total Non-current Assets | 180.94M | 228.19M | 179.84M | 166.25M | 168.92M |
| Total Assets | 809.18M | 704.96M | 831.69M | 556.54M | 824.91M |
| Account Payables | 2.5M | 10.98M | 6.59M | 7.23M | 5.17M |
| Short-term Debt | 5.77M | 8.38M | 0 | 0 | 3.86M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 13.01M | 11.12M | 0 | 0 | 20.49M |
| Other Current Liabilities | 2.87M | 28.23M | 45.91M | 19.12M | 23.46M |
| Total Current Liabilities | 36.76M | 75.92M | 73.68M | 40.05M | 62.92M |
| Long-term Debt | 100.96M | 102.79M | 101.75M | 51.32M | 522.9M |
| Deferred Tax Liabilities | 12.91M | 8.26M | 7.54M | 7.04M | 7.97M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 33.78M | 10.27M | 412.74M | 453.73M | 22.39M |
| Total Non-current Liabilities | 176.64M | 153.04M | 550.34M | 523.24M | 563.09M |
| Total Liabilities | 213.4M | 228.96M | 624.02M | 563.29M | 626.01M |
| Common Stock | 2.8M | 2.84M | 2.88M | 2.95M | 3.69M |
| Retained Earnings | (455.14M) | (581.93M) | (890.41M) | (1.13B) | (1.33B) |
| Accumulated OCI | (28.86M) | (58.29M) | (53.55M) | (52.8M) | (58.22M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 595.78M | 476.01M | 207.67M | (6.75M) | 198.9M |
| Total Debt | 135.72M | 142.89M | 138.41M | 66.06M | 536.59M |
| Net Debt | (420.53M) | (85.12M) | (102.95M) | (92.87M) | 456.35M |
uniQure N.V.
NASDAQ:QURE
Intrinsic Alpha fair value
Locked
Current Price
$20.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.